Department of Pathological Physiology, Medical Faculty, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic,
Genes Nutr. 2009 Sep;4(3):207-13. doi: 10.1007/s12263-009-0130-9. Epub 2009 Jul 16.
The aim of this study was to investigate the possible associations between insertion/deletion (ID) polymorphism in angiotensin-converting enzyme (ACE) (dbSNP rs 4646994) with the food intake and body composition in the Czech non-obese, obese and extremely obese populations. A total of 453 various-weighted individuals were enrolled in the study and were according to their BMI assigned into following subgroups, such as obese (30 </= BMI < 40), morbidly obese (BMI >/=40) and non-obese (20 < BMI < 30) subjects. Both the obese cases and the non-obese controls underwent the identical subset of standardized examinations (BMI, % body fat, waist-to-hip ratio, skin fold thickness, native dietary composition examined by 7-day food records, etc.). No significant case-control differences in genotype distributions or allelic frequencies were observed. There were no differences in genotype frequencies between males and females either. The prevalence of obesity was significantly higher among subjects with the II genotype (42 %) when compared with those with DD (36%) and those with ID (37%) genotypes (P = 0.04). When compared with carbohydrate intake in the whole studied cohort, the odds ratios of carrying the DD allele in the morbidly obese cohort were 0.84 (95% CI 0.34, 2.10, P = 0.17), 0.27 (0.07, 0.98, P = 0.02), and 4.25 (1.44, 12.51, P = 0.005) in those individuals consuming <210, 210-260, and >260 g of carbohydrates/day, respectively. Based on our findings, the ID ACE polymorphism could represent a gene modulator of carbohydrate intake in morbidly obese Czech population; the strong significant effect of DD genotype was observed in the phenotypes of extreme obesity with the highest carbohydrate intake.
本研究旨在探讨血管紧张素转换酶(ACE)插入/缺失(ID)多态性(dbSNP rs4646994)与捷克非肥胖、肥胖和极度肥胖人群的食物摄入和身体成分之间可能存在的关联。共有 453 名不同体重的个体参与了这项研究,并根据他们的 BMI 被分为以下亚组,如肥胖(30 <= BMI < 40)、病态肥胖(BMI >= 40)和非肥胖(20 < BMI < 30)。肥胖病例和非肥胖对照组都接受了相同的标准化检查(BMI、体脂肪百分比、腰臀比、皮褶厚度、通过 7 天食物记录检查的原生饮食成分等)。基因型分布或等位基因频率在病例对照之间没有显著差异。男性和女性之间的基因型频率也没有差异。与 DD(36%)和 ID(37%)基因型相比,携带 II 基因型的个体肥胖的患病率明显更高(42%)(P=0.04)。与整个研究队列的碳水化合物摄入量相比,病态肥胖队列中携带 DD 等位基因的个体的比值比为 0.84(95%CI 0.34, 2.10,P=0.17)、0.27(0.07, 0.98,P=0.02)和 4.25(1.44, 12.51,P=0.005),分别摄入<210、210-260 和>260 g 碳水化合物/天。根据我们的发现,ACE 基因的 ID 多态性可能代表了捷克病态肥胖人群碳水化合物摄入的基因调节剂;在最高碳水化合物摄入的极度肥胖表型中,DD 基因型具有很强的显著影响。